Cargando…

Endometrial Carcinoma: Immune Microenvironment and Emerging Treatments in Immuno-Oncology

Endometrial cancer (EC) can easily be cured when diagnosed at an early stage. However, advanced and metastatic EC is a common disease, affecting more than 15,000 patients per year in the United Sates. Only limited treatment options were available until recently, with a taxane–platinum combination as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rousset-Rouviere, Sandrine, Rochigneux, Philippe, Chrétien, Anne-Sophie, Fattori, Stéphane, Gorvel, Laurent, Provansal, Magali, Lambaudie, Eric, Olive, Daniel, Sabatier, Renaud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228955/ https://www.ncbi.nlm.nih.gov/pubmed/34199461 http://dx.doi.org/10.3390/biomedicines9060632

Ejemplares similares

Endometrial Tumor Microenvironment Alters Human NK Cell Recruitment, and Resident NK Cell Phenotype and Function
por: Degos, Clara, et al.
Publicado: (2019)

CD25(high) Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
por: Fattori, Stéphane, et al.
Publicado: (2023)

Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease
por: Mari, Roxane, et al.
Publicado: (2019)

Quantification of Immune Variables from Liquid Biopsy in Breast Cancer Patients Links Vδ2(+) γδ T Cell Alterations with Lymph Node Invasion
por: Fattori, Stéphane, et al.
Publicado: (2021)

Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy
por: Wlosik, J., et al.
Publicado: (2022)

PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences are Emerging—A Literature Review
por: Planes-Laine, Gabrielle, et al.
Publicado: (2019)

High-throughput mass cytometry staining for deep phenotyping of human natural killer cells
por: Ben Amara, Amira, et al.
Publicado: (2022)

Prognostic Immune Effector Signature in Adult Acute Lymphoblastic Leukemia Patients Is Dominated by γδ T Cells
por: Le Floch, Anne-Charlotte, et al.
Publicado: (2023)

High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome
por: Chretien, Anne-Sophie, et al.
Publicado: (2021)

Immuno-Oncology
por: Chaudhuri, Swapna
Publicado: (2017)

Early clinical outcomes of hybrid brachytherapy for locally advanced cervical cancer: making adverse situations in a favorable scenario
por: Cagetti, Leonel Varela, et al.
Publicado: (2022)

Multi-Omics Profiling of the Tumor Microenvironment: Paving the Way to Precision Immuno-Oncology
por: Finotello, Francesca, et al.
Publicado: (2018)

A review of spatial profiling technologies for characterizing the tumor microenvironment in immuno-oncology
por: Hu, Bian, et al.
Publicado: (2022)

Immuno‐Oncology in China
por: Lu, Shun, et al.
Publicado: (2019)

Radiomics in immuno-oncology
por: Bodalal, Z., et al.
Publicado: (2021)

The Role of Radiation Oncology in Immuno‐Oncology
por: Meng, Xiangjiao, et al.
Publicado: (2019)

A novel immuno-oncology algorithm measuring tumor microenvironment to predict response to immunotherapies
por: Nielsen, Tyler J., et al.
Publicado: (2021)

IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures
por: Zeng, Dongqiang, et al.
Publicado: (2021)

Autologous humanized PDX modeling for immuno-oncology recapitulates features of the human tumor microenvironment
por: Chiorazzi, Michael, et al.
Publicado: (2023)

Dysthyroidism during immune checkpoint inhibitors is associated with improved overall survival in adult cancers: data mining of 1385 electronic patient records
por: Beaufils, Mathilde, et al.
Publicado: (2023)

Mevalonate Metabolism in Immuno-Oncology
por: Gruenbacher, Georg, et al.
Publicado: (2017)

Immuno-Oncology Essentials: An Overview
por: Hoffner, Brianna
Publicado: (2019)

Multiplex imaging in immuno-oncology
por: Zhao, Chen, et al.
Publicado: (2023)

Soluble BTN2A1 Is a Potential Prognosis Biomarker in Pre-Treated Advanced Renal Cell Carcinoma
por: Billon, Emilien, et al.
Publicado: (2021)

Immunodynamics of explanted human tumors for immuno‐oncology
por: Dubuisson, Agathe, et al.
Publicado: (2020)

Challenges and Opportunities in Dose Finding in Oncology and Immuno‐oncology
por: Ji, Yan, et al.
Publicado: (2018)

The New Immuno-Oncology-Based Therapies and Their Perspectives in Hepatocellular Carcinoma
por: Merle, Philippe
Publicado: (2021)

Immuno-cardio-oncology: Killing two birds with one stone?
por: Van Linthout, Sophie, et al.
Publicado: (2022)

Editorial: Immuno-Metabolism in Tumor Microenvironment
por: Prado-García, Heriberto, et al.
Publicado: (2017)

Glycolysis-cholesterol metabolic axis in immuno-oncology microenvironment: emerging role in immune cells and immunosuppressive signaling
por: Jin, Jing, et al.
Publicado: (2023)

Statistical issues and challenges in immuno-oncology
por: Chen, Tai-Tsang
Publicado: (2013)

Immunotherapies and Combination Strategies for Immuno-Oncology
por: Barbari, Cody, et al.
Publicado: (2020)

Necroptosis in Immuno-Oncology and Cancer Immunotherapy
por: Sprooten, Jenny, et al.
Publicado: (2020)

Immuno-oncology for B-cell lymphomas
por: Choi, Yoon Seok
Publicado: (2021)

Virus-Based Immuno-Oncology Models
por: Sitta, Juliana, et al.
Publicado: (2022)

Organoids as an Enabler of Precision Immuno-Oncology
por: Zhao, Junzhe, et al.
Publicado: (2023)

Single-Cell Analysis in Immuno-Oncology
por: Christodoulou, Maria-Ioanna, et al.
Publicado: (2023)

The Role of PRMT5 in Immuno-Oncology
por: Abe, Yoshinori, et al.
Publicado: (2023)

Racing CARs to veterinary immuno-oncology
por: Cockey, James R., et al.
Publicado: (2023)

Targeting the “PVR–TIGIT axis” with immune checkpoint therapies
por: Gorvel, Laurent, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m91tj2us2c03kafvclh9mhvihn